A PYMNTS Company

India: Approval granted for pharmaceutical sale

By  |  September 21, 2016

The Competition Commission of India approved Piramal Enterprises’ $16.5 million purchase four brands of pharmaceuticals from Pfizer Ltd.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The acquisition was announced in May and includes the brands of Ferradol, Neko, Sloan’s and Waterbury’s Compound as well as trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka.

    Full Content: The Economic Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.